Exploring Next-Line Options in HER2- MSS Gastric Cancer

Opinion
Video

Experts discuss other therapies or clinical trials that might be explored after trastuzumab deruxtecan, particularly for patients with HER2-positive microsatellite-stable (MSS) adenocarcinoma and progression on multiple lines of therapy.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
6 experts are featured in this series.
6 experts are featured in this series.
Related Content